Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study
Open Access
- 7 March 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (3), e0213096
- https://doi.org/10.1371/journal.pone.0213096
Abstract
We propose renin angiotensin system (RAS) peptides are critical in wound reparative processes such as in acute respiratory distress syndrome (ARDS). Their role in predicting clinical outcomes in ARDS has been unexplored; thus, we used a targeted metabolomics approach to investigate them as potential predictors of outcomes. Thirty-nine ARDS patients were enrolled within 24 hours of ARDS diagnosis. Plasma RAS peptide levels were quantified at study entry and 24, 48 and 72 hours using a liquid chromatography-mass spectrometry based metabolomics assay. RAS peptide concentrations were compared between survivors and non-survivors, and were correlated with clinical and pulmonary measures. Angiotensin I (Ang-I or A(1–10)) levels were significantly higher in non-survivors at study entry and 72 hours. ARDS survival was associated with lower A(1–10) concentration (OR 0.36, 95% CI 0.18–0.72, p = 0.004) but higher A(1–9) concentration (OR 2.24, 95% CI 1.15–4.39, p = 0.018), a biologically active metabolite of A(1–10) and an agonist of angiotensin II receptor type 2. Survivors had significantly higher median A(1–9)/A(1–10) and A(1–7)/A(1–10) ratios than the non-survivors (p = 0.001). Increased A(1–9)/A(1–10) ratio suggests that angiotensin converting enzyme II (ACE2) activity is higher in patients who survived their ARDS insult while an increase in A(1–7)/A(1–10) ratio suggests that ACE activity is also higher in survivors. A(1–10) accumulation and reduced A(1–9) concentration in the non-survivor group suggest that ACE2 activities may be reduced in patients succumbing to ARDS. Plasma levels of both A(1–10) and A(1–9) and their ratio may serve as useful biomarkers for prognosis in ARDS patients.Keywords
This publication has 23 references indexed in Scilit:
- “Obesity Paradox” in Acute Respiratory Distress Syndrome: Asystematic Review and Meta-AnalysisPLOS ONE, 2016
- ACE inhibition, ACE2 and angiotensin-(17) axis in kidney and cardiac inflammation and fibrosisPharmacological Research, 2016
- ACE and ACE2 in Inflammation: A Tale of Two EnzymesInflammation & Allergy - Drug Targets, 2014
- Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targetsNature Reviews Cardiology, 2014
- Angiotensin-converting enzyme 2 activity in patients with chronic kidney diseaseNephrology Dialysis Transplantation, 2013
- Acute Respiratory Distress SyndromeJAMA, 2012
- Plasma angiopoietin-2 in clinical acute lung injuryCritical Care Medicine, 2012
- Angiotensin-(1-9) Attenuates Cardiac Fibrosis in the Stroke-Prone Spontaneously Hypertensive Rat via the Angiotensin Type 2 ReceptorHypertension, 2012
- Analytic Review: The Pathogenetic and Prognostic Value of Biologic Markers in Acute Lung InjuryJournal of Intensive Care Medicine, 2009
- Incidence and Outcomes of Acute Lung InjuryThe New England Journal of Medicine, 2005